Isracann Biosciences Inc. (ISCNF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: May 2, 2025

Isracann Biosciences Balance Sheet

Millions CAD. Fiscal year is Jun - May.
Fiscal Year
TTM FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Aug '22 May '22 May '21 May '20 May '19
Cash & Equivalents
0.20.211.963.894.18
Cash & Short-Term Investments
0.20.211.963.894.18
Cash Growth
-85.84%-89.08%-49.67%-6.87%-
Other Receivables
0.080.080.210.240.18
Receivables
0.080.080.210.240.68
Prepaid Expenses
0.020.050.080.180.44
Restricted Cash
----10.15
Other Current Assets
---1.16-
Total Current Assets
0.30.342.255.4815.45
Property, Plant & Equipment
0.040.050.090.120.89
Long-Term Investments
--0.250.27-
Other Intangible Assets
3.73.7-20.62-
Long-Term Deferred Charges
----0.03
Other Long-Term Assets
--1.291.3-
Total Assets
4.044.094.428.2716.37
Accounts Payable
0.40.310.450.710.93
Accrued Expenses
0.630.610.010.050.1
Other Current Liabilities
---0.97-
Total Current Liabilities
1.030.920.471.721.04
Other Long-Term Liabilities
2.892.89---
Total Liabilities
3.913.80.471.721.04
Common Stock
63.162.8762.0156.8911.74
Retained Earnings
-77.14-76.82-72.13-43.79-19.59
Comprehensive Income & Other
14.1714.2514.0613.4523.18
Total Common Equity
0.130.293.9426.5615.33
Minority Interest
-0-0-0-0-
Shareholders' Equity
0.120.293.9426.5615.33
Total Liabilities & Equity
4.044.094.428.2716.37
Net Cash (Debt)
0.20.211.963.894.18
Net Cash Growth
-85.84%-89.08%-49.67%-6.87%-
Net Cash Per Share
0.000.000.010.040.11
Filing Date Shares Outstanding
175.99175.99146.08134.1938.31
Total Common Shares Outstanding
162.97158.29146.08134.1938.31
Working Capital
-0.73-0.571.793.7614.41
Book Value Per Share
0.000.000.030.200.40
Tangible Book Value
-3.57-3.43.945.9415.33
Tangible Book Value Per Share
-0.02-0.020.030.040.40
Land
----0.06
Buildings
0.070.070.070.073.44
Machinery
0.140.140.140.130.78
Source: S&P Global Market Intelligence. Standard template. Financial Sources.